TOKYO -- Nikkei will add 12 stocks, including Dai-ichi Life Holdings, to the Nikkei Progressive and High Dividend Stock Index as part of its periodic review, while removing 12 stocks, such as Sumitomo Mitsui Trust Group.
The company will also review the Nikkei Consecutive Dividend Growth Stock Index, adding three stocks, including Sekisui House, and removing Astellas Pharma.
Changes to both indexes will take effect from calculations on June 30.
For the Nikkei Progressive and High Dividend Stock Index, constituents are selected based on stocks with a high number of instances of maintaining or increasing dividends, known as progressive dividends, and are ranked by forecast dividend yield.
The Nikkei Consecutive Dividend Growth Stock Index selects stocks based on the number of consecutive dividend increases. Both indices use data as of the end of May as a reference.
The Nikkei Dividend Growth Stock Index will see fewer deletions than additions, reflecting prior removals made since the last annual review.
For more details, please visit the Nikkei indexes website.
